Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 6 papers. Top paper: “Phase 3 study of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) as front-line treatment for advanced classical Hodgkin lymphoma (HL): Echelon-1 study.”.
Anas Younes, Joseph M. Connors, Andrea Gallamini, Won Seog Kim, Jonathan W. Friedberg +10 more
Peipei Lu, Wen Xie, Jingyuan Wang
Ye Feng, Brian Liu, Wen Xie, Jingyuan Wang
Ziteng Zhang, Jibin Guan, Hung‐Chun Tung, Jiaxuan Xie, Haozhe Huang +8 more
Jong‐Won Kim, Junjie Zhu, Sihan Li, Jiong Yan, Qing Liu +21 more
Gregory Young, Min Zhang, Sonia R. Salvatore, Fu‐Ying Qin, Xinran Cai +13 more